Covid-19 Treatments

Hydroxychloroquine shows no benefit in coronavirus study

A new study published in the New England Journal of Medicine found no evidence of benefit from using Hydroxychloroquine as a treatment for coronavirus infection.

The study that involved 1,376 patients claims the drug did not lower the risk of dying or needing a breathing tube.

Science • Medicine
Remdesivir trial results show efficacy in Covid-19 treatment

The US National Institute of Allergy and Infectious Diseases has been running a trial of Remdesivir on 1,063 randomly assigned patients hospitalised with Covid-19. The group who got the Remdesivir treatment showed a median time of recovery of 11 days, while those who got a placebo averaged on a 15 day recovery. Mortality rate was 8% for the Remdesivir group and 11.6% for the placebo group.